Myelodysplastic Syndromes

Showing NaN - NaN of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Worldwide (amifostine trihydrate)

Completed
  • Myelodysplastic Syndromes
  • Myelodysplastic/Myeloproliferative Neoplasms
  • amifostine trihydrate
  • Phoenix, Arizona
  • +84 more
Feb 11, 2014

MDS Trial in Canada, United States (Obatoclax mesylate (GX15-070MS))

Completed
  • Myelodysplastic Syndromes
  • Obatoclax mesylate (GX15-070MS)
  • Stanford, California
  • +21 more
Aug 16, 2013

Acute Myelogenous Leukemia, MDS, Chronic Myelogenous Leukemia Trial in Dallas (Clofarabine and Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Clofarabine and Cytarabine
  • Dallas, Texas
    Baylor University Medical Center
Jul 15, 2013

Kidney Cancer, Leukemia, Lymphoma Trial in United States (voriconazole)

Completed
  • Kidney Cancer
  • +8 more
  • Orange, California
  • +6 more
Jun 18, 2013

Chronic Myeloproliferative Disorders, Infection, Leukemia Trial in United States (amphotericin B deoxycholate, nystatin)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • Phoenix, Arizona
  • +58 more
Mar 25, 2013

Leukemia, Lymphoma, MDS Trial in United States (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • +3 more
  • anti-thymocyte globulin
  • +9 more
  • Duarte, California
  • +24 more
Mar 3, 2011

MDS Trial in United States (TLK199 HCl Liposomes for Injection)

Completed
  • Myelodysplastic Syndromes
  • TLK199 HCl Liposomes for Injection
  • Birmingham, Alabama
  • +8 more
May 30, 2008

MDS Trial in United States (thalidomide)

Completed
  • Myelodysplastic Syndromes
  • La Jolla, California
  • +37 more
Jun 23, 2005